(Q34419982)

2 August 2017

The antidepressant metapramine is a low-affinity antagonist at N-methyl-D-aspartic acid receptors (English)

1 reference

2 August 2017

Boireau A

1

1 reference

2 August 2017

Bordier F

series ordinal

2

1 reference

2 August 2017

Durand G

series ordinal

3

1 reference

2 August 2017

Doble A

series ordinal

4

1 reference

2 August 2017

1 January 1996

1 reference

2 August 2017

1 reference

2 August 2017

35

1 reference

2 August 2017

1703-1707

1 reference

2 August 2017

12

1 reference

Glutamate: A Neurotransmitter in Mammalian Brain

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

Excitatory amino acid receptors and guanosine 3',5'-cyclic monophosphate in incubated slices of immature and adult rat cerebellum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

Modulation of Mg2+-dependent [3H]TCP binding byL-glutamate, glycine, and guanine nucleotides in rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

The Glycine Site of the N-Methyl-D-Aspartate Receptor Channel: Differences Between the Binding of HA-966 and of 7-Chlorokynurenic Acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

N-methyl-D-aspartic acid receptor structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

Clinical experience with excitatory amino acid antagonist drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

The role of excitatory amino acids in experimental models of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

Down-regulation of cortical beta-adrenoceptors by chronic treatment with functional NMDA antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

Cooperative modulation of [3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

The NMDA receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900122-0

10.1016/S0028-3908(96)00122-0

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference